Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SMT GROUP logo — Making life wonderful again!

SMT GROUP

Making life wonderful again!

Founded 2019 China China 22 employees Series C Total: $100.00M Biopharma, Health Care

General Information

Company Name SMT GROUP
Founded Year 2019
Location China China
Employees 22
Industries Biopharma, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with SMT GROUP. To contact SMT GROUP, visit smtworld.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SMT GROUP

SMT Group is a China-based high-tech enterprise founded in 2019, specializing in the biopharmaceutical and health care industries. The company focuses on blood purification and offers a wide range of products, including raw materials and assembly lines, with a particular emphasis on hollow fiber membranes, hollow fiber hemodialyzers, and Dialyzer Assembly System (DAS). SMT Group boasts an impressive annual production capacity of 12 million bundles of hollow fiber membrane and 10 million pieces of hollow fiber dialyzers. The most recent funding round saw SMT Group secure a significant CNY100.00M Series C investment on 08 September 2023. Notably, the investors in this round included Shunwei Capital, CCB Equity, and Neovision Capital - an indicator of the company's appeal to a diverse range of investors. With a compelling slogan "Making life wonderful again!", SMT Group is poised to make a lasting impact in the biopharmaceutical and health care sectors.

Taxonomy: Biopharmaceuticals, Blood purification, Hemodialysis, Medical technology, Hollow fiber membranes, Dialyzers, Membrane science, Tangential flow filter, High-tech enterprise, Raw materials, Medical devices, China

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY100.00M 3
Shunwei Capital CCB Equity Neovision Capital
Shunwei Capital, CCB Equity +1
08 Sep 2023
Series C Undisclosed 2
China Life Private Equity Investment, CICC Qide
14 Jun 2023

SMT GROUP Alternatives & Competitors

View All Alternatives
SMT GROUP vs
Promea Therapeutics
Promea Therapeutics India

Your Health. Our Promise.

210 employees
Biopharma, Biotechnology
SMT GROUP vs
Biocon
Biocon India

Transforming Healthcare. Transforming Lives.

IPO
11576 employees
Biopharma, Biotechnology
SMT GROUP vs
ACELYRIN, INC.
ACELYRIN, INC. United States

We are a late-stage clinical biopharma company focused on providing life-changing new treatment opti...

Acquired
103 employees
Biopharma, Biotechnology
View all alternatives

FAQ About SMT GROUP

Making life wonderful again!
SMT GROUP was founded in 2019.
SMT GROUP is headquartered in China.
SMT GROUP operates in Biopharma and Health Care. Its work centres on Biopharmaceuticals, Blood purification, Hemodialysis and Medical technology.
SMT GROUP has approximately 22 employees.
SMT GROUP has completed 2 funding rounds, raising a total of $100.00M. The latest funding stage is Series C.
Top alternatives and competitors to SMT GROUP include Promea Therapeutics, Biocon, ACELYRIN, INC., Eden Biologics, ZYUS Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SMT GROUP and Promea Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SMT GROUP, https://bouncewatch.com/company/smt-group, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes